Intrinsic Value of S&P & Nasdaq Contact Us

Air Products and Chemicals, Inc. APD NYSE

NYSE • Basic Materials • Chemicals - Specialty • US • USD

SharesGrow Score
39/100
1/7 Pass
SharesGrow Intrinsic Value
$296.65
+0%
Analyst Price Target
$291.50
-1.7%
SharesGrow 7-Criteria Score All 7 criteria scored · valuation-related highlighted on this page

Air Products and Chemicals, Inc. (APD) has a negative trailing P/E of -198.7, meaning the company is currently unprofitable on a trailing twelve-month (TTM) basis. The forward P/E of 22.8 based on analyst estimates suggests a return to profitability is expected. Trailing earnings yield is -0.50%, forward earnings yield 4.39%. PEG 3.56.

Criteria proven by this page:

  • VALUE (35/100, Fail) — negative P/E indicates the company is currently operating at a loss — DCF and P/E-based valuation models cannot produce meaningful results for unprofitable companies (P/E -198.7); trailing earnings yield is below the 10-year Treasury yield (~4.3%), meaning bonds offer a better return (EY -0.50%); PEG > 2.0 means the stock is expensive even after accounting for growth (PEG 3.56).
  • Forward P/E 22.8 — analysts expect a return to profitability with estimated EPS of $13.03 for FY2026.
  • PEG Ratio 3.56 — above 2.0 suggests expensive relative to earnings growth.
  • Trailing Earnings Yield -0.50% — negative yield confirms the company is currently unprofitable. Investors are paying for a turnaround rather than current earnings. Forward yield improves to 4.39% as earnings recover.
  • Analyst consensus target $291.50 (-1.7% downside) — slight downside risk — the market may be ahead of analyst expectations.

Overall SharesGrow Score: 39/100 with 1/7 criteria passed.

SharesGrow 7-Criteria Score
39/100
SG Score
View full scorecard →
VALUE
35/100
Price-to-Earnings & upside
Proven by this page
FUTURE
38/100
Analyst consensus
→ Forecast
~
PAST
75/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
→ Health
MOAT
70/100
→ Income
GROWTH
15/100
→ Income
INCOME
10/100
→ Income

Valuation Snapshot — APD

Valuation Multiples
P/E (TTM)-198.7
Forward P/E22.8
PEG Ratio3.56
Forward PEG3.56
P/B Ratio4.30
P/S Ratio5.43
EV/EBITDA59.0
Per Share Data
EPS (TTM)$-1.50
Forward EPS (Est.)$13.03
Book Value / Share$80.06
Revenue / Share$54.79
FCF / Share$-12.61
Yields & Fair Value
Earnings Yield-0.50%
Forward Earnings Yield4.39%
Dividend Yield2.41%
SharesGrow IV$296.65 (+0%)
Analyst Target$291.50 (-1.7%)

Historical Valuation

Year P/E (TTM) PEG Ratio P/B Ratio P/S Ratio Dividend Yield
2016 47.7 -0.94 4.25 4.01 2.40%
2017 11.0 0.03 3.27 4.03 2.39%
2018 24.8 -0.49 3.42 4.16 2.42%
2019 27.8 1.64 4.42 5.48 2.03%
2020 34.9 4.65 5.45 7.44 1.67%
2021 27.0 4.07 4.19 5.50 2.21%
2022 22.9 2.21 3.93 4.07 2.68%
2023 27.4 13.85 4.40 5.00 2.38%
2024 17.3 0.26 3.89 5.47 2.36%
2025 -154.0 1.40 4.04 5.05 2.61%

EPS: Actual vs Estimates

P/E Ratio & Earnings Yield

Earnings Per Share (EPS) History

Year EPS (Diluted) Revenue Net Income Net Margin
2016 $2.89 $7.5B $631.1M 8.4%
2017 $13.65 $8.19B $3B 36.6%
2018 $6.78 $8.93B $1.5B 16.8%
2019 $7.94 $8.92B $1.76B 19.7%
2020 $8.55 $8.86B $1.89B 21.3%
2021 $9.12 $10.32B $2.1B 20.3%
2022 $10.08 $12.7B $2.26B 17.8%
2023 $10.30 $12.6B $2.3B 18.3%
2024 $17.18 $12.1B $3.83B 31.6%
2025 $-1.77 $12.04B $-394.5M -3.3%

Analyst Estimates

Year EPS (Avg) EPS Range Revenue (Avg) Revenue Range Analysts
2026 $13.03 $12.97 – $13.07 $12.59B $12.23B – $12.82B 13
2027 $14.02 $13.80 – $14.17 $13.31B $12.51B – $13.97B 12
2028 $15.16 $14.71 – $15.96 $13.97B $13.92B – $14.02B 6
2029 $18.25 $17.16 – $19.05 $15.89B $15.16B – $16.43B 3
2030 $16.67 $15.67 – $17.41 $15.29B $14.59B – $15.81B 2
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message